May 3rd, 2024, 13:50 - 14:00 WEST

FCO-49 A phase II, randomized, double blind study to evaluate the efficacy and safety of AMY109 in women with endometriosis

    Endometriosis 2
Powered by
Run your next event
with Fourwaves